CrossrefInfokarte
RETRACTION: Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting I κ B α /NF κ B and Enhancing Nrf2/HO‐1
Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)
DOI: 10.1155/omcl/9843608 ↗Abstract
Kein Abstract verfügbar.
EUVIMED